The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Amgen is currently a Zacks Rank ...

Stock Advisor returns as of April 1, 2025 David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amgen, Baidu, and PayPal. The Motley Fool ...

One factor that keeps some investors away from healthcare stocks is the sector's dearth of generous and reliable dividend payers. This stands to reason, as nearly every stage of drug development and ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Amgen is currently a Zacks Rank #3 (Hold).

with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.14% higher. As of now, Amgen holds a Zacks Rank of #3 (Hold).

This multi-factor model seeks low volatility stocks that also have strong momentum and high net payout yields. AMGEN INC (AMGN) is a large-cap growth stock in the Biotechnology & Drugs industry.

Deep-pocketed investors have adopted a bearish approach towards Amgen (NASDAQ:AMGN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

In its press release trumpeting the FDA's move, Amgen quoted its executive vice ... just identified what they believe are the 10 best stocks for investors to buy now… and Catalyst ...

As of Monday, the Nasdaq Composite index had tumbled more than 11% since the start of the year. The outlook for the economy ...

Our analysis of options history for Amgen (NASDAQ:AMGN) revealed 19 unusual trades. Delving into the details, we found 26% of traders were bullish, while 63% showed bearish tendencies. Out of all ...